Advertisement

Nursing

Home Nursing
The World Health Organization has suspended use of the antimalarial drug hydroxychloroquine in a clinical trial of treatments of COVID-19 after a study revealed that patients taking the drug are at increased risk for death and serious heart problems.

WHO Suspends Testing of Hydroxychloroquine in COVID-19 Patients

In light of recent findings, hydroxychloroquine arm of WHO global study paused temporarily